Manipal Health IPO Gains Momentum in Udupi, Experts Weigh In

The Manipal Health IPO has been making headlines in Udupi, with many investors eager to know whether to apply or avoid the issue. The Grey Market Premium (GMP) has been fluctuating, making it a crucial factor in investors' decisions.

The IPO, which is expected to raise Rs 4,000 crore, has been seen as a promising opportunity for investors. However, experts are warning that the GMP is not a reliable indicator of the IPO's performance.

According to experts, the GMP is influenced by various factors, including market sentiment and the overall economic condition. They also caution that the GMP is not a guarantee of the IPO's success.

Source: Google News – Manipal.